Circulating adiponectin levels and their associated factors in young lean healthy Japanese women

Journal of Atherosclerosis and Thrombosis

Volumn 20, Issue 1, 2013, Pages 57-64

  Takahara, Mitsuyoshi ^a   Katakami, Naoto ^a   Kishida, Ken ^a   Kaneto, Hideaki ^a   Funahashi, Tohru ^a   Shimomura, Iichiro ^a   Matsunaga, Sai ^b   Kubo, Satoko ^b   Fukamizu, Hideaki ^b   Otsuka, Akihito ^b   Ichihara, Kikuo ^b   Nakamura, Tadashi ^b  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Kawasaki Hospital   (Japan)

Author keywords

Adiponectin; eGFR; HDL cholesterol; Young healthy Japanese women

Indexed keywords

ADIPONECTIN; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CREATININE; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD PRESSURE; BODY MASS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLOMERULUS FILTRATION RATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; NORMAL HUMAN; WAIST CIRCUMFERENCE;

ADIPONECTIN; ADULT; ANTHROPOMETRY; BLOOD GLUCOSE; CREATININE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLOMERULAR FILTRATION RATE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LIPIDS; REFERENCE VALUES;

EID: 84873826828     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.14357     Document Type: Article

References (52)

1. Maeda K, Okubo K, Shimomura I, Funahashi T, Matsuzawa Y, Matsubara K: cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). Biochem Biophys Res Commun, 1996; 221: 286-289
2. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, Kuriyama H, Nishida M, Yamashita S, Okubo K, Matsubara K, Muraguchi M, Ohmoto Y, Funahashi T, Matsuzawa Y: Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun, 1999; 257: 79-83
3. Matsuzawa Y, Funahashi T, Nakamura T: The concept of metabolic syndrome: contribution of visceral fat accumulation and its molecular mechanism. J Atheroscler Thromb, 2011; 18: 629-639
4. Kishida K, Kim KK, Funahashi T, Matsuzawa Y, Kang HC, Shimomura I: Relationships between circulating adiponectin levels and fat distribution in obese subjects. J Atheroscler Thromb, 2011; 18: 592-595
5. Daimon M, Oizumi T, Saitoh T, Kameda W, Hirata A, Yamaguchi H, Ohnuma H, Igarashi M, Tominaga M, Kato T: Decreased serum levels of adiponectin are a risk factor for the progression to type 2 diabetes in the Japanese Population: the Funagata study. Diabetes Care, 2003; 26: 2015-2020
6. Lindsay RS, Funahashi T, Hanson RL, Matsuzawa Y, Tanaka S, Tataranni PA, Knowler WC, Krakoff J: Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet, 2002; 360: 57-58
7. Spranger J, Kroke A, Mohlig M, Bergmann MM, Ristow M, Boeing H, Pfeiffer AF: Adiponectin and protection against type 2 diabetes mellitus. Lancet, 2003; 361: 226-228
8. Snehalatha C, Mukesh B, Simon M, Viswanathan V, Haffner SM, Ramachandran A: Plasma adiponectin is an independent predictor of type 2 diabetes in Asian indians. Diabetes Care, 2003; 26: 3226-3229
9. Duncan BB, Schmidt MI, Pankow JS, Bang H, Couper D, Ballantyne CM, Hoogeveen RC, Heiss G: Adiponectin and the development of type 2 diabetes: the atherosclerosis risk in communities study. Diabetes, 2004; 53: 2473-2478
10. Schnabel R, Messow CM, Lubos E, Espinola-Klein C, Rupprecht HJ, Bickel C, Sinning C, Tzikas S, Keller T, Genth-Zotz S, Lackner KJ, Munzel TF, Blankenberg S: Association of adiponectin with adverse outcome in coronary artery disease patients: results from the AtheroGene study. Eur Heart J, 2008; 29: 649-657
11. Nakamura Y, Shimada K, Fukuda D, Shimada Y, Ehara S, Hirose M, Kataoka T, Kamimori K, Shimodozono S, Kobayashi Y, Yoshiyama M, Takeuchi K, Yoshikawa J: Implications of plasma concentrations of adiponectin in patients with coronary artery disease. Heart, 2004; 90: 528-533
12. Xu XT, Xu Q, Tong JL, Zhu MM, Huang ML, Ran ZH, Xiao SD: Meta-analysis: circulating adiponectin levels and risk of colorectal cancer and adenoma. J Dig Dis, 2011; 12: 234-244
13. An W, Bai Y, Deng SX, Gao J, Ben QW, Cai QC, Zhang HG, Li ZS: Adiponectin levels in patients with colorectal cancer and adenoma: a meta-analysis. Eur J Cancer Prev, 2012; 21: 126-133
14. Miyoshi Y, Funahashi T, Kihara S, Taguchi T, Tamaki Y, Matsuzawa Y, Noguchi S: Association of serum adiponectin levels with breast cancer risk. Clin Cancer Res, 2003; 9: 5699-5704
15. Goktas S, Yilmaz MI, Caglar K, Sonmez A, Kilic S, Bedir S: Prostate cancer and adiponectin. Urology, 2005; 65: 1168-1172
16. Jurimae J, Jurimae T: Plasma adiponectin concentration in healthy pre- and postmenopausal women: relationship with body composition, bone mineral, and metabolic variables. Am J Physiol Endocrinol Metab, 2007; 293: E42-47
17. Ryo M, Nakamura T, Kihara S, Kumada M, Shibazaki S, Takahashi M, Nagai M, Matsuzawa Y, Funahashi T: Adiponectin as a biomarker of the metabolic syndrome. Circ J, 2004; 68: 975-981
18. Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem, 1972; 18: 499-502
19. Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A: Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis, 2009; 53: 982-992
20. Kashiwagi A, Kasuga M, Araki E, Oka Y, Hanafusa T, Ito H, Tominaga M, Oikawa S, Noda M, Kawamura T, Sanke T, Namba M, Hashiramoto M, Sasahara T, Nishio Y, Kuwa K, Ueki K, Takei I, Umemoto M, Murakami M, Yamakado M, Yatomi Y, H. O, Committee on the Standardization of Diabetes Mellitus-Related Laboratory Testing of Japan Diabetes Society: International clinical harmonization of glycated hemoglobin in Japan: From Japan Diabetes Society to National Glycohemoglobin Standardization Program values. J Diabetes Invest, 2012; 3: 39-40
21. Japan Atherosclerosis Society: Japan Atherosclerosis Society (JAS) guidelines for prevention of atherosclerotic cardiovascular diseases 2012, Kyorinsha, Tokyo, 2012 (in Japanese)
22. The Japanese Society of Hypertension: Guidelines for the management of hypertension (JSH2009), Life Science Publication, Tokyo, 2009 (in Japanese)
23. The Japan Diabetes Society: Evidence-based Practice Guideline for the Treatment of Diabetes in Japan, Nankodo, Tokyo, 2010 (in Japanese)
24. Seino Y, Nanjo K, Tajima N, Kadowaki T, Kashiwagi A, Araki E, Ito C, Inagaki N, Iwamoto Y, Kasuga M, Hanafusa T, Haneda M, Ueki K: Report of the Committee on the classification and diagnostic criteria of diabetes mellitus: The Committee of the Japan Diabetes Society on the diagnostic criteria of diabetes mellitus. J Diabetes Invest, 2010; 1: 212-228
25. The Examination Committee of Criteria for the Metabolic Syndrome in Japan: Definition and diagnostic criteria of the metabolic syndrome. J Japan Soc Intern Med, 2005; 94: 794-809 (in Japanese)
26. Nakagawa Y, Kishida K, Funahashi T, Yanagi K, Shimomura I: Coexistence of Visceral Fat Accumulation and Sleep-Disordered Breathing Correlates with Coronary Artery Disease. J Atheroscler Thromb, 2012; doi: 10.5551/jat.13227
27. Tamura Y, Murayama T, Minami M, Matsubara T, Yokode M, Arai H: Ezetimibe Ameliorates Early Diabetic Nephropathy in db/db Mice. J Atheroscler Thromb, 2012; doi: 10.5551/jat.11312
28. Yamaguchi T, Miyashita Y, Saiki A, Watanabe F, Watanabe H, Shirai K: Formula diet is effective for the reduction and differentiation of visceral adipose tissue in Zucker fatty rats. J Atheroscler Thromb, 2012; 19: 127-136
29. Kurobe H, Aihara K, Higashida M, Hirata Y, Nishiya M, Matsuoka Y, Kanbara T, Nakayama T, Kinoshita H, Sugano M, Fujimoto E, Kurobe A, Sugasawa N, Kitaichi T, Akaike M, Sata M, Matsumoto T, Kitagawa T: Ezetimibe monotherapy ameliorates vascular function in patients with hypercholesterolemia through decreasing oxidative stress. J Atheroscler Thromb, 2011; 18: 1080-1089
30. Park JS, Kang SA, Yoo JS, Ahn CW, Cha BS, Kim KR, Lee HC: Association between gamma-glutamyltransferase, adiponectin and arterial stiffness. J Atheroscler Thromb, 2012; 19: 90-97
31. Arai Y, Takayama M, Abe Y, Hirose N: Adipokines and aging. J Atheroscler Thromb, 2011; 18: 545-550
32. Baessler A, Schlossbauer S, Stark K, Strack C, Riegger G, Schunkert H, Hengstenberg C, Fischer M: Adiponectin multimeric forms but not total adiponectin levels are associated with myocardial infarction in non-diabetic men. J Atheroscler Thromb, 2011; 18: 616-627
33. Cohen SS, Gammon MD, Signorello LB, North KE, Lange EM, Fowke JH, Hargreaves MK, Cai Q, Zheng W, Blot WJ, Matthews CE: Serum adiponectin in relation to body mass index and other correlates in black and white women. Ann Epidemiol, 2011; 21: 86-94
34. Hulver MW, Saleh O, MacDonald KG, Pories WJ, Barakat HA: Ethnic differences in adiponectin levels. Metabolism, 2004; 53: 1-3
35. Pereira RI, Wang CC, Hosokawa P, Dickinson LM, Chonchol M, Krantz MJ, Steiner JF, Bessesen DH, Havranek EP, Long CS: Circulating adiponectin levels are lower in Latino versus non-Latino white patients at risk for cardiovascular disease, independent of adiposity measures. BMC Endocr Disord, 2011; 11: 13
36. Isobe T, Saitoh S, Takagi S, Takeuchi H, Chiba Y, Katoh N, Shimamoto K: Influence of gender, age and renal function on plasma adiponectin level: the Tanno and Sobetsu study. Eur J Endocrinol, 2005; 153: 91-98
37. Saraheimo M, Forsblom C, Fagerudd J, Teppo AM, Pettersson-Fernholm K, Frystyk J, Flyvbjerg A, Groop PH: Serum adiponectin is increased in type 1 diabetic patients with nephropathy. Diabetes Care, 2005; 28: 1410-1414
38. Schalkwijk CG, Chaturvedi N, Schram MT, Fuller JH, Stehouwer CD: Adiponectin is inversely associated with renal function in type 1 diabetic patients. J Clin Endocrinol Metab, 2006; 91: 129-135
39. Zoccali C, Mallamaci F, Tripepi G, Benedetto FA, Cutrupi S, Parlongo S, Malatino LS, Bonanno G, Seminara G, Rapisarda F, Fatuzzo P, Buemi M, Nicocia G, Tanaka S, Ouchi N, Kihara S, Funahashi T, Matsuzawa Y: Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. J Am Soc Nephrol, 2002; 13: 134-141
40. Matsuura F, Oku H, Koseki M, Sandoval JC, Yuasa-Kawase M, Tsubakio-Yamamoto K, Masuda D, Maeda N, Tsujii K, Ishigami M, Nishida M, Hirano K, Kihara S, Hori M, Shimomura I, Yamashita S: Adiponectin accelerates reverse cholesterol transport by increasing high density lipoprotein assembly in the liver. Biochem Biophys Res Commun, 2007; 358: 1091-1095
41. Oku H, Matsuura F, Koseki M, Sandoval JC, Yuasa-Kawase M, Tsubakio-Yamamoto K, Masuda D, Maeda N, Ohama T, Ishigami M, Nishida M, Hirano K, Kihara S, Hori M, Shimomura I, Yamashita S: Adiponectin deficiency suppresses ABCA1 expression and ApoA-I synthesis in the liver. FEBS Lett, 2007; 581: 5029-5033
42. Mallamaci F, Zoccali C, Cuzzola F, Tripepi G, Cutrupi S, Parlongo S, Tanaka S, Ouchi N, Kihara S, Funahashi T, Matsuzawa Y: Adiponectin in essential hypertension. J Nephrol, 2002; 15: 507-511
43. Barlovic DP, Zaletel J, Prezelj J: Adipocytokines are associated with renal function in patients with normal range glomerular filtration rate and type 2 diabetes. Cytokine, 2009; 46: 142-145
44. Risch L, Saely C, Hoefle G, Rein P, Langer P, Gouya G, Marte T, Aczel S, Drexel H: Relationship between glomerular filtration rate and the adipokines adiponectin, resistin and leptin in coronary patients with predominantly normal or mildly impaired renal function. Clin Chim Acta, 2007; 376: 108-113
45. Looker HC, Krakoff J, Funahashi T, Matsuzawa Y, Tanaka S, Nelson RG, Knowler WC, Lindsay RS, Hanson RL: Adiponectin concentrations are influenced by renal function and diabetes duration in Pima Indians with type 2 diabetes. J Clin Endocrinol Metab, 2004; 89: 4010-4017
46. Guebre-Egziabher F, Bernhard J, Funahashi T, Hadj-Aissa A, Fouque D: Adiponectin in chronic kidney disease is related more to metabolic disturbances than to decline in renal function. Nephrol Dial Transplant, 2005; 20: 129-134
47. Komura N, Kihara S, Sonoda M, Maeda N, Tochino Y, Funahashi T, Shimomura I: Increment and impairment of adiponectin in renal failure. Cardiovasc Res, 2010; 86: 471-477
48. Koshimura J, Fujita H, Narita T, Shimotomai T, Hosoba M, Yoshioka N, Kakei M, Fujishima H, Ito S: Urinary adiponectin excretion is increased in patients with overt diabetic nephropathy. Biochem Biophys Res Commun, 2004; 316: 165-169
49. Uetani E, Tabara Y, Igase M, Kido T, Ochi N, Takita R, Kohara K, Miki T: Liver Enzyme and Adipocytokine Profiles are Synergistically Associated with Insulin Resistance: the J-SHIPP Study. J Atheroscler Thromb, 2012; doi: 10.5551/jat.11924
50. Kotani K, Hazama A, Hagimoto A, Saika K, Shigeta M, Katanoda K, Nakamura M: Adiponectin and Smoking Status: A Systematic Review. J Atheroscler Thromb, 2012; doi: 10.5551/jat.11833
51. Hara K, Uchida T, Takebayashi K, Sakai Y, Inoue T, Inukai T, Takayanagi K, Aso Y: Determinants of serum high molecular weight (HMW) adiponectin levels in patients with coronary artery disease: associations with cardio-renalanemia syndrome. Intern Med, 2011; 50: 2953-2960
52. Imhof A, Plamper I, Maier S, Trischler G, Koenig W: Effect of drinking on adiponectin in healthy men and women: a randomized intervention study of water, ethanol, red wine, and beer with or without alcohol. Diabetes Care, 2009; 32: 1101-1103